Cancer Cell-Intrinsic PD-1 and immune-microenvironment boost tumor growth upon immune-checkpoint inhibitors in NSCLC
Funding Organization: MFAG AIRC
Principal Investigator: Dott. Lo Russo Giuseppe
Start date:
End date:
Main Facility: Oncologia Medica 1 - Unità Oncologia Medica Melanomi
Study on tumor- or tumor microenvironment-related mechanisms underlying the phenomenon of hyperprogressive disease in patients treated with immunotherapeutic agents.
Principal Investigator Dr. Lo Russo Giuseppe
Struttura Principale: Medical Oncology 1 – Medical Oncology Unit: Melanoma
Clinical Area, Simple Structure
Thoracic Oncology Unit
Clinical Area, Simple Structure
Molecular Immunology
Research Area, Complex Structure
Last update: 26/05/2025